Search Results - "Crook, T.J."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    A randomized controlled trial of nephrostomy placement versus tubeless percutaneous nephrolithotomy by Crook, T J, Lockyer, C R, Keoghane, S R, Walmsley, B H

    Published in The Journal of urology (01-08-2008)
    “…We established whether totally tubeless percutaneous nephrolithotomy with no nephrostomy or ureteral stent is a safe management technique. Patients were…”
    Get more information
    Journal Article
  2. 2

    Femoral nerve neuropathy following the psoas hitch procedure by Crook, T.J, Steinbrecher, H.A, Tekgul, S, Malone, P.S.J

    Published in Journal of pediatric urology (01-04-2007)
    “…Abstract Objective To present two cases of femoral nerve neuropathy following a psoas hitch procedure performed during Leadbetter–Politano ureteric…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A case series of nephrogenic adenoma of the urethra and bladder in children: Review of this rare diagnosis, its natural history and management, with reference to the literature by Crook, T.J., Mead, Z., Vadgama, B., Malone, P.S.J.

    Published in Journal of pediatric urology (01-08-2006)
    “…Nephrogenic adenoma (NA) is a rare benign tumour of the urinary tract and is found most commonly in the bladder. Here are presented four cases of paediatric…”
    Get full text
    Journal Article
  5. 5

    Intravesical Meglumine Gamma-Linolenic Acid in Superficial Bladder Cancer: An Efficacy Study by Harris, N.M, Crook, T.J, Dyer, J.P, Solomon, L.Z, Bass, P, Cooper, A.J, Birch, B.R

    Published in European urology (01-07-2002)
    “…Objectives: Gamma-linolenic acid (GLA) is known to be cytotoxic to malignant cells. We assessed the efficacy of the novel intravesical formulation, meglumine…”
    Get full text
    Journal Article
  6. 6

    Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer by Harris, N.M., Duffy, P.M., Crook, T.J., Anderson, W.R., Sharpe, P., Hayes, M.C., Cooper, A.J., Solomon, L.Z.

    Published in BJU international (01-12-2002)
    “…Objective  To assess, using epirubicin‐sensitive and multidrug resistant (MDR) derivatives of human bladder cancer cell lines in vitro, the probable effect of…”
    Get full text
    Journal Article
  7. 7

    A model of superficial bladder cancer using fluorescent tumour cells in an organ‐culture system by Crook, T.J., Hall, I.S., Solomon, L.Z., Birch, B.R., Cooper, A.J.

    Published in BJU international (01-11-2000)
    “…Objective To develop a reproducible in vitro simulation of superficial bladder cancer for testing cytotoxic agents at clinically relevant concentrations…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Effects of the δ‐opioid receptor antagonist naltrindole on antinociceptive responses to selective δ‐agonists in post‐weanling rats by Crook, T.J., Kitchen, I., Hill, R.G.

    Published in British journal of pharmacology (01-10-1992)
    “…1 Antagonism, by the selective δ‐opioid receptor antagonist naltrindole, of the antinociceptive effects of [d‐Pen2, d‐Pen5] enkephalin (DPDPE), [d‐Ser2, Leu5,…”
    Get full text
    Journal Article